More than two years after Medtronic first hitched its wagon to Mazor Robotics, the pair is making it official through an acquisition valued at $1.64 billion, or $1.34 billion net of Medtronic's existing stake in Mazor and cash acquired.
News & Features
InTouch Health is building an Internet of Medical Things for Intuitive Surgical that could also benefit other medical device companies and healthcare systems.
Aromyx Corp. announces its groundbreaking biosensor technology based on the human sense of smell and taste. The company says the new technology has the potential to be used as a diagnostic tool to detect early stage cancer and disease.
Two separate studies show how researchers are using machine learning to train computers to spot and classify cells just by analyzing medical images.
Quadrant Biosciences scored a $2 million NIH grant to supports its epigenetic diagnostic test for autism spectrum disorder.
LivaNova is launching a pivotal study that will look at how stimulation of the vagus nerve with the VITARIA device can help treat heart failure patients.
The company’s Phoenix device is a bioelectric medicine that has the potential to treat functional diseases such as type-2 diabetes, hypertension, and gastroesophageal reflux disease.
Seven key trends and events helped make Liquid Biopsy attractive to investors, shareholders, patients, and physicians.
Medtronic also received FDA approval for revised TAVR labeling that marks a critical moment for treating patients with bicuspid severe aortic stenosis.
Financings, joint ventures, and clearances continue to drive the quickly growing surgical robotics market.
Appreciate the promise of digital health technology as well as the challenges faced when launching a product, advises an expert speaking at MD&M Minneapolis.
New data unveiled at the European Respiratory Society International Congress shows that the Archimedes virtual bronchoscopy navigation system significantly improves the diagnostic yield of lung cancer nodules located outside a patient's main airways.